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1.1. Discovery of MptpB inhibitors from a click chemistry library
Protein tyrosine phosphatases (PTPs) are important cellular sig-
nalling enzymes, and have been identiﬁed as important drug tar-
gets. Amongst the PTPs, Mycobactrium tuberculosis PTP (MptpB)
presents a promising target for the treatment of tuberculosis. A re-
cent paper describes the preparation of a library of around 3500
triazole compounds prepared using click chemistry and their
screening against MptpB.1
A collection of 11 alkynes (1) containing the known cell-perme-
able carboxyisoxazole bioisostere for phosphotyrosine, and a col-
lection of 325 diverse azides (2) were reacted by Cu(I)-catalysed
1,3-dipolar cycloaddition in 384-well microtitre plates using an
automated liquid handling system. The 3500 click chemistry
products (3), assembled in a matter of days to weeks, were de-
signed to take advantage of both the phosphotyrosine binding site
and a secondary binding site recently identiﬁed in the structure of
MptpB using X-ray crystallography. Around 10% of the products
generated were characterised by LC–MS and were conﬁrmed to
be of good purity (>90% for most compounds).
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The compounds were screened against recombinant MptpB en-
zyme and the assay results plotted as a heat map. It was clear that
one alkyne in particular — that containing a cyclohexyl group ortho
to the isoxazole — gave products that were signiﬁcantly more po-
tent than other derivatives. The presence of the cyclohexyl group
increased afﬁnity for MptpB by some 24-fold. In particular, com-
pound 4 showed a Ki value of 150 nM against MptpB, and is thedoi:10.1016/j.comche.2009.12.002
E-mail: nterrett@ensemblediscovery.commost potent inhibitor for this target reported in the literature. This
and other inhibitors showed an 11- to 43-fold selectivity over
other PTPs tested.
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1.2. Parallel click chemistry to make CDC25 phosphatase inhibitors
CDC25 phosphatases are key regulatory enzymes of the cell cy-
cle, and present attractive targets for cancer therapy. There are
three isoforms, A, B and C, of which isoforms A and B are found
up-regulated in aggressive and chemotherapy-resistant metastatic
diseases. Following the recent identiﬁcation of a benzylidene–
thiazolopyrimidine (BTP) structure (e.g. 5) as a novel CDC25 inhib-
itor, the use of copper-catalysed click chemistry to make new
CDC25 phosphatase inhibitors has been reported.2
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Modelling of the BTP system and the CDC25 phosphatase indi-
cated that the benzodioxolone and ester groups were interacting
with the catalytic site of the enzyme. The phenol moiety appeared
to be occupying an adjacent binding pocket, and it was hypothe-
sised that binding to this area of the phosphatase could be further
investigated by modiﬁcation through a triazole generated using
click chemistry. The phenyl group of the novel triazolobenzylid-
ene–thiazolopyrimidines (TBTPs) (6) was used as an ortho-,
meta-, or para- directing scaffold, and the wide range of commer-
cially available alkynes provided the scope of diversity for the click
chemistry. The azido-BTP precursors (7) were obtained by
condensing azidobenzaldehydes (8) with the thiazolopyrimidine
precursor (9) in a Knoevenagel reaction using piperidine catalyst
in ethanol.
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Click chemistry was carried out using copper sulphate and 10%
sodium ascorbate in NMP; the solvent being chosen speciﬁcally to
allow dilution with aqueous buffer so that the reaction products
(6) could be directly submitted to an enzyme assay without further
work up. Parallel synthesis was undertaken in 96-well plates using
29 terminal alkynes to react with each of the azides for 5 days at
ambient temperature, giving nearly every product in essentially
quantitative yields. Biological screening of the compounds at
10 lM indicated that none of the ortho- ormeta- products were ac-
tive, but that several para-TBTP derivatives were potential CDC25
phosphatase inhibitors. Resynthesis and puriﬁcation of several
compounds indicated that several had IC50 values in the lowmicro-
molar concentration range.
2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
A recent study has demonstrated that Fmoc-aminoacyl-N-
ethyl-S-triphenylmethylcysteine can be used to prepare peptide
thioesters by Fmoc solid-phase peptide synthesis (SPPS). This ap-
proach was used for the SPPS of a known decapeptide, and gave
a remarkable increase (44%) in the overall yield of the decapeptid-
ethioester, compared to the 7% obtained by the stepwise on-resin
Leu–Cys condensation method.3
A traceless solid supported protocol for the synthesis of 2-amin-
obenzothiazoles has been described, employing resin-bound acyl-
isothiocyanate and a series of anilines. Cyclisation of the resulting
N-acyl, N0-phenyl-thioureas generated the 2-aminobenzothiazole
scaffold, which was further elaborated, prior to hydrazine-medi-
ated cleavage, to give a small, focussed library of 2-aminobenzo-
thiazoles.4
2.2. Solution-phase synthesis
A general method has been developed for the synthesis of
1,3-disubstituted-imidazo[1,5-a]quinazolin-5-(4H)-ones. This pro-
cess involves initial microwave-assisted quinazolinone formation
between anthranilamide and various Boc- or acylamino acids,followed by intramolecular cyclodehydration under acidic
conditions. This method has now been adapted to the synthesis of
diverse screening libraries of related imidazoquinazolinones, which
can be employed as intermediates in the synthesis of bioactive
compounds.5
2.3. Scaffolds and synthons for combinatorial libraries
Novel tricyclic dipyridoimidazole derivatives can be readily
synthesised in one-pot processes from various highly ﬂuorinated
pyridine systems such as pentaﬂuoropyridine and relatively nucle-
ophilic 2-aminopyridine derivatives. Further nucleophilic aromatic
substitution reactions of the novel tricyclic scaffolds allow the reg-
ioselective synthesis of various nitrogen, oxygen, carbon and sul-
phur-functionalised dipyridoimidazole products.6
2.4. Solid-phase supported reagents
A polystyrene-supported palladium(0) complex [PS-dpp-Pd(0)]
has been shown to be an efﬁcient catalyst for the copper- and sol-
vent-free acylation of terminal alkynes with different acid chlo-
rides in the presence of triethylamine as base, giving the
corresponding ynones in good yields.7
Potassium ﬂuoride was found to be an efﬁcient catalyst for the
synthesis of 3,5-disubstituted-1,2,4-oxadiazoles. A one-pot meth-
od for the synthesis of these compounds from the reaction of ni-
triles with hydroxylamine hydrochloride and acyl chloride in the
presence of solid supported potassium ﬂuoride under solvent-free
conditions using microwave irradiation has been developed.8
2.5. Novel resins, linkers and techniques
No papers this month.2.6. Library applications
Laterocidin and its analogues have been synthesised for the ﬁrst
time by a solid-phase synthesis method. The peptide was attached,
via linking of the carboxyl group on the side chain of aspartate, to
Rink resin with the protection of side chain a-carboxyl group of
aspartate by Dmab as a temporary a-COOH protecting group for
the on-resin cyclisation. One analogue demonstrated potent and
broad antimicrobial properties, in particular, activity against clini-
cal Methicillin-resistant Staphylococcus aureus (L-MRSA) and the
gram-negative extended-spectrum b-lactamases-producing Esche-
richia coli (ESBLs E. coli) and L-E.coli.9
A combinatorial library of 10,358 compounds on solid support
has been synthesised using a pool-and-split technique and tested
for activity against Mycobacterium tuberculosis. Structure–activity
relationship (SAR) evaluation identiﬁed new compounds with anti-
tubercular activity, including a novel hit series that is structurally
unrelated to any existing antitubercular drugs.10
Thepreviously describedSARof benzimidazole-basednon-nucle-
oside ﬁnger loop inhibitors of HCV NS5B polymerase has been ex-
panded. Prospecting studies using parallel synthesis techniques has
allowed the rapid identiﬁcation of novel cinnamic acid right-hand
sides that provide renewed opportunities for further optimisation.11
A chemically diverse library of secondary and tertiary 4-cyanom-
ethyl-1,5-diphenyl-1H-pyrazole-3-carboxamideshasbeensynthes-
ised toenablemappingof theSAR forCB1antagonist activity. Several
compounds with single-digit or even sub-nanomolar potency, suit-
able for further elaboration of the nitrile moiety, were identiﬁed.12
In the course of modiﬁcation of isoxazolopyridone mGluR7
antagonists, a novel solid supported synthesis of the isoxazolopyri-
done scaffold was developed. Subsequent chemical modiﬁcation
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proved physicochemical properties.13
An iterative analogue library synthesis approach was employed
in the exploration of a quinolone carboxylic acid series of selective
M1 positive allosteric modulators, and strategies for improving po-
tency and plasma free fraction were identiﬁed.14
ProteinsbearingaCaaLsequenceare typicallygeranylgeranylated
to enable their proper localization and function. Many of the dansyl-
GCaaL peptides representingmammalian CaaL proteins can be farn-
esylated by FTase, and synthesis and screening of a CaaL peptide
libraryversusFTasehas revealedasurprisingnumberof substrates.15
8,8-Diphenyl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-ami
ne, identiﬁed through HTS as a weak (micromolar) inhibitor of
BACE1, was optimised using structure-based focussed libraries.16
A chemical lead optimisation campaign has been directed at
VU0238429, the ﬁrst M5-preferring positive allosteric modulator
(PAM). An iterative library synthesis approach delivered the ﬁrst
selective M5 PAM (no activity at M1–M4 at 30 lM), and an impor-
tant tool compound to study the role of M5 in the CNS.17
The selectin–leukocyte interaction proceeds via the terminal
tetrasaccharide sialyl Lewisx (sLex), present on physiological selec-
tin ligands. A small library of competitive sLex mimetics have been
prepared possessing the carboxylic acid pharmacophore equipped
with additional hydrophobic substituents as neuraminic acid
(Neu5Ac) replacements.18
Twenty-four asymmetric divalent head group cholesterol-based
cationic lipids have been designed and synthesised by parallel so-
lid-phase chemistry. These asymmetric head groups were com-
posed of amino functionality together with trimethylamino, di(2-
hydroxyethyl)amino or guanidinyl groups and were subjected to
evaluation for DNA binding afﬁnities by gel retardation assay and
were screened for their transfection efﬁciency on HEK293 cells.19
Colon tumour cell growth inhibitory agents have been investi-
gated through a combinatorial approach. Two series of 4,6-dia-
ryl-2-oxo-1,2 dihydropyridine-3-carbonitriles and their isosteric
4,6-diaryl-2-imino-1,2-dihydropyridine-3-carbonitriles were syn-
thesised through a one-pot reaction of the appropriate acetophe-
none, aldehyde, ammonium acetate with ethyl cyanoacetate or
malononitrile. The compounds were evaluated for inhibitory activ-
ity against the human HT-29 colon tumour cell line, as well as for
their PDE3 inhibitory activity.20
A genetic screen for isolating ‘lariat’ peptides that function as
trans dominant inhibitors of protein function has been developed.
A lariat consists of a lactone-cyclised peptide with a covalently
attached transcription activation domain, which allows combina-
torial lariat libraries to be screened for protein interactions using
the yeast two-hybrid assay.21
Antigen-speciﬁc T cells play a major role in mediating the path-
ogenesis of a variety of autoimmune conditions as well as other
diseases. A general approach to the discovery of highly speciﬁc li-
gands for autoreactive cells has been described where the ligands
are obtained from a combinatorial library of hundreds of thou-
sands of synthetic peptoids that is screened simultaneously against
two populations of CD4+T cells providing a powerful tool for the
enrichment and inhibition of autoimmune cells in a variety of dis-
ease states.22
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